 The study evaluated the effect of TNF inhibitors on the risk of myocardial infarction, MI, in psoriasis patients compared with methotrexate, MTX, and topical agents, finding that both TNF inhibitor and MTX cohorts showed a statistically lower rate of MI compared with topical cohort, but there was no significant difference between TNF inhibitor and MTX cohorts. Additionally, the probability of MI was lower in TNF inhibitor responders compared with non-responders. This article was authored by Dalia Shaban and Nawaf Omitari.